Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR01:59

CRISPR

52.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.8K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

204
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
204

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epstein-Barr virus (EBV) infection causes human germinal center B cell-derived lymphomas in the absence of EBNA2 expression.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Integrating Epstein-Barr virus (EBV) status into diffuse large B cell lymphoma (DLBCL) genetics.

bioRxiv : the preprint server for biology·2026
Same author

Kaposi sarcoma-associated herpesvirus cooperates with Epstein-Barr virus to co-transform a small set of human B cells oncogenically.

PLoS pathogens·2025
Same author

Assessing the fitness of Epstein-Barr virus following its reactivation.

Journal of virology·2025
Same author

A Critical Role for Epstein-Barr Virus in Primary Effusion Lymphoma.

Current topics in microbiology and immunology·2025
Same author

How Epstein Barr Virus Causes Lymphomas.

Viruses·2024
Same journal

A Multitask Prediction Framework for CircRNAs, Drugs, and Diseases Based on Multi-View Information Integration and Graph Contrastive Learning.

ACS synthetic biology·2026
Same journal

Engineering Modular Cargo Loading Strategies for Carboxysome-Derived Protein Particles.

ACS synthetic biology·2026
Same journal

Suppression of Salmonella Effectors with CRISPRi Controls the Immune Response to Bacterial Therapies.

ACS synthetic biology·2026
Same journal

Rational Design of Linalool Dehydratase-Isomerase Enables Efficient Conversion of Phytol to Neophytadiene.

ACS synthetic biology·2026
Same journal

<i>De Novo</i> Biosynthesis of Polyphyllin V in <i>Nicotiana benthamiana</i> through Pathway Reconstruction and UDP-Sugar Engineering.

ACS synthetic biology·2026
Same journal

Rapid and Continuous Directed Evolution in <i>Vibrio natriegens</i> Utilizing an <i>In Vivo</i> Hypermutation System.

ACS synthetic biology·2026
See all related articles

Related Experiment Video

Updated: Sep 6, 2025

Pooled CRISPR-Based Genetic Screens in Mammalian Cells
09:05

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Published on: September 4, 2019

22.2K

Optimal LentiCRISPR-Based System for Sequential CRISPR/Cas9 Screens.

Rebecca L Hutcheson1, Mitchell Hayes1, Bill Sugden1

  • 1McArdle Laboratory for Cancer Research, University of Wisconsin─Madison, 1111 Highland Ave., Madison, Wisconsin 53705, United States.

ACS Synthetic Biology
|June 29, 2022
PubMed
Summary
This summary is machine-generated.

We introduce "Many vs One" CRISPR screening, a novel method using a modified 7SK promoter. This approach enhances genome-wide CRISPR knockout screens for biological discovery without needing larger libraries.

Keywords:
7SK promoterCRISPR/Cas9LentiCRISPRscreeningsequential screen

More Related Videos

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens
08:49

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Published on: June 6, 2020

14.7K
Using Sniper-Cas9 to Minimize Off-target Effects of CRISPR-Cas9 Without the Loss of On-target Activity Via Directed Evolution
11:37

Using Sniper-Cas9 to Minimize Off-target Effects of CRISPR-Cas9 Without the Loss of On-target Activity Via Directed Evolution

Published on: February 26, 2019

9.9K

Related Experiment Videos

Last Updated: Sep 6, 2025

Pooled CRISPR-Based Genetic Screens in Mammalian Cells
09:05

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Published on: September 4, 2019

22.2K
Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens
08:49

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Published on: June 6, 2020

14.7K
Using Sniper-Cas9 to Minimize Off-target Effects of CRISPR-Cas9 Without the Loss of On-target Activity Via Directed Evolution
11:37

Using Sniper-Cas9 to Minimize Off-target Effects of CRISPR-Cas9 Without the Loss of On-target Activity Via Directed Evolution

Published on: February 26, 2019

9.9K

Area of Science:

  • Molecular Biology
  • Genomics
  • Genetic Engineering

Background:

  • Genome-wide clustered regularly interspaced short palindromic repeats (CRISPR) screening significantly advances cellular molecular systems understanding.
  • Existing CRISPR screening methods often require extensive library coverage, increasing processing and sequencing demands.

Purpose of the Study:

  • To present a novel sequential CRISPR knockout screening strategy named "Many vs One" CRISPR screening.
  • To demonstrate the utility of this approach for exploring biological questions across the human genome efficiently.
  • To introduce a modified 7SK promoter system for improved CRISPR screening.

Main Methods:

  • Development of a modified lentiCRISPRv2 vector utilizing a 7SK promoter instead of the U6 promoter for single-guide RNA expression.
  • Implementation of sequential CRISPR knockout screens, where initial genome-wide screens are followed by focused screens of gene candidates against a common gene.
  • Comparison of the 7SK vector's performance against the standard U6 promoter in terms of lentiviral titer, knockout efficiency, and usability.

Main Results:

  • The novel 7SK promoter enables "Many vs One" CRISPR screening, reducing the need for increased CRISPR library coverage.
  • This method allows for sequential analysis, using remaining cells to test multiple gene candidates against a single gene of interest.
  • The 7SK vector demonstrates comparable lentiviral titer, knockout efficiency, and ease of use to the original lentiCRISPRv2 vector.

Conclusions:

  • The "Many vs One" CRISPR screening approach, powered by the 7SK promoter, offers a more efficient and versatile tool for genetic screening.
  • This methodology streamlines screening processes, sample handling, and next-generation sequencing requirements.
  • The 7SK promoter integration into the lentiCRISPRv2 backbone provides a valuable advancement for CRISPR-based biological discovery.